We use cookies to improve the functionality and performance of this site. By continuing to use this site, you are providing us with your consent to our use of cookies on the site. Please see our Privacy Policy for details.

Team Experience Thought Leadership About Press Room Locations Careers
Related Sites
MWE China Law Offices McDermott+Consulting
MENU McDermott Will & Emery
Languages
Deutsch English Français Italiano
McDermott Will & Emery
Team Experience Thought
Leadership
About Press
Room
Locations Careers
Languages
Deutsch English Français Italiano

Team / Richard B. Smith

Connect Share pdf your pages
  • {{page.name}}
  • Linked In
    Linked In
  • Xing
    Xing
  • Twitter
    Twitter
  • Facebook
    Facebook
  • Email This
    Email This
  • PDF
    PDF
  • Print
    Print
Smith Richard B Smith Richard B

Richard B. Smith

Partner

Boston

t: +1 617 535 3876 f: +1 617 535 3800
{{navLabel}}
  • Overview
  • Results
  • Credentials
  • Thought Leadership
  • Press Room

Richard B. Smith focuses his practice on representation of life sciences companies and related transactions. He has served as counsel to public, private and emerging life sciences companies, advising those companies on strategic business transactions such as licensing, joint ventures, and collaborations involving research, development, marketing, supply, clinical development and co-promotion of pharmaceutical, diagnostic and medical device products.

Richard also advises companies on other corporate issues common to life sciences companies, including corporate formation of new ventures, venture capital, private equity, venture philanthropy and other forms of financing, mergers and acquisitions, as well as university and institutional licensing and intellectual property strategies.

Results

  • Represented a Dutch biopharmaceutical company in a strategic collaboration with a major pharmaceutical company involving oligonucleotide therapeutic products for an orphan drug indication in a deal valued at more than $650 million
  • Represented a publicly held biopharmaceutical company in strategic deals with several major pharmaceutical companies for the development and commercialization of nucleotide-based immune modulators for applications as divers as asthma, allergies and cancer; the transaction related to cancer was publicly valued at more than $500 million
  • Represented a publicly held biopharmaceutical company in a strategic license and development deal with a major pharmaceutical company involving a therapeutic cancer vaccine in a deal valued at more than $440 million
  • Advised a publicly held biopharmaceutical company in the purchase of certain biotech products from a large publicly held biotechnology company
  • Acted as a key member of a team representing a large Japanese pharmaceutical company in its multibillion-dollar acquisition of a publicly held biotechnology company

Credentials

Education
  • Suffolk University Law School, JD
  • Rensselaer Polytechnic Institute, ME
  • Rensselaer Polytechnic Institute, BS
Admissions
  • Massachusetts
Courts / Agencies
  • US Patent and Trademark Office

Thought Leadership

All Publications Events
  • {{insightsItem.title}} {{insightsItem.title}}
    {{insightsItem.title}}
    {{insightsItem.title}}

    {{insightsItem.source}}
    {{insightsItem.pubType}}
    {{insightsItem.displayDate}}
    {{insightsItem.pubType}}
    {{insightsItem.displayDate}}
    {{insightsItem.displayDate}} |
    {{insightsItem.listingImageAlternateText}} {{insightsItem.listingImageAlternateText}}
    {{insightsItem.listingImageAlternateText}}
    {{insightsItem.listingImageAlternateText}}
  • View More
  • {{insightsItem.title}} {{insightsItem.title}}
    {{insightsItem.title}}
    {{insightsItem.title}}

    {{insightsItem.publicationName}}
    {{insightsItem.source}}
    {{insightsItem.pubType}} {{insightsItem.displayDate}}
    {{insightsItem.listingImageAlternateText}} {{insightsItem.listingImageAlternateText}}
    {{insightsItem.listingImageAlternateText}}
    {{insightsItem.listingImageAlternateText}}
  • View More
  • {{insightsItem.title}} {{insightsItem.title}}
    {{insightsItem.title}}
    {{insightsItem.title}}

    {{insightsItem.displayDate}} |
    {{insightsItem.listingImageAlternateText}} {{insightsItem.listingImageAlternateText}}
    {{insightsItem.listingImageAlternateText}}
    {{insightsItem.listingImageAlternateText}}
  • View More

Press Room

All Press Releases Coverage Accolades Coverage
  • {{newsItem.title}}
    {{newsItem.title}}
    {{newsItem.title}}

    {{newsItem.publicationName}} {{newsItem.displayDate}}
    {{newsItem.listingImageAlternateText}}
  • View More
  • {{newsItem.title}}

    {{newsItem.publicationName}} {{newsItem.displayDate}}
    {{newsItem.listingImageAlternateText}}
  • View More
  • {{newsItem.title}}

    {{newsItem.publicationName}} {{newsItem.displayDate}}
    {{newsItem.listingImageAlternateText}}
  • View More
  • {{newsItem.title}} {{newsItem.title}}

    {{newsItem.publicationName}} {{newsItem.displayDate}}
    {{newsItem.listingImageAlternateText}}
  • View More
  • {{newsItem.title}} {{newsItem.title}}

    {{newsItem.publicationName}} {{newsItem.displayDate}}
    {{newsItem.listingImageAlternateText}}
  • View More

Credentials

Education
  • Suffolk University Law School, JD
  • Rensselaer Polytechnic Institute, ME
  • Rensselaer Polytechnic Institute, BS
Admissions
  • Massachusetts
Courts / Agencies
  • US Patent and Trademark Office

Core Capabilities

  • Corporate & Transactional
  • Licensing & Collaborative Arrangements
  • Life Sciences Entrepreneurs Acceleration Program (LEAP)
  • Mergers & Acquisitions

Regional Markets

  • United States

© 2018 McDermott Will & Emery

Legal Notices Imprint Privacy and Cookies Policy Client Connect Connect@McDermott Contact Us
Related Sites MWE China Law Offices McDermott+Consulting
Attorney Advertising